Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pure Bioscience (PURE)
OTHER OTC:PURE
Holding PURE?
Track your performance easily
PURE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.06 - $0.16
Previous CloseN/A
Volume1.63K
Average Volume (3M)86.06K
Market Cap
$7.39M
Enterprise Value$13.60M
Total Cash (Recent Filing)$1.64M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.92
Next Earnings
Mar 12, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding111,856,476
10 Day Avg. Volume97,947
30 Day Avg. Volume86,064
Standard Deviation0.26
R-Squared0.00015
Alpha0.00374
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.22
Price to Cash Flow (P/CF)-4.70
P/FCF Ratio0.00
Enterprise Value/Market Cap1.84
Enterprise Value/Revenue7.57
Enterprise Value/Gross Profit11.81
Enterprise Value/Ebitda-4.37
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Pure Bioscience News
Options Prices
Currently, No data available
---
Ownership Overview
40.91%
Insiders
0.72% Other Institutional Investors
58.37% Public Companies and
Individual Investors
PURE FAQ
What was Pure Bioscience’s price range in the past 12 months?
Pure Bioscience lowest stock price was $0.06 and its highest was $0.16 in the past 12 months.
What is Pure Bioscience’s market cap?
Pure Bioscience’s market cap is $7.39M.
When is Pure Bioscience’s upcoming earnings report date?
Pure Bioscience’s upcoming earnings report date is Mar 12, 2025 which is in 51 days.
How were Pure Bioscience’s earnings last quarter?
Pure Bioscience released its earnings results on Dec 16, 2024. The company reported -$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.006.
Is Pure Bioscience overvalued?
According to Wall Street analysts Pure Bioscience’s price is currently Overvalued.
Does Pure Bioscience pay dividends?
Pure Bioscience does not currently pay dividends.
What is Pure Bioscience’s EPS estimate?
Pure Bioscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pure Bioscience have?
Pure Bioscience has 111,856,476 shares outstanding.
What happened to Pure Bioscience’s price movement after its last earnings report?
Pure Bioscience reported an EPS of -$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 16.667%.
Which hedge fund is a major shareholder of Pure Bioscience?
Currently, no hedge funds are holding shares in PURE
---
Company Description
Pure Bioscience
PURE Bioscience, Inc. engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.
---
Technical Analysis
WD-40 Company
―
Central Garden Pet
―
Spectrum Brands Holdings
―
Oil-Dri Of America
―
Sunset Capital Assets
―
Pet Ecology Brands
―
---